Valganciclovir Therapy Prevents Human Cytomegalovirus Reactivation in Glioblastoma Patients Undergoing Radiochemotherapy and Extends Time to Tumor Progression.
Saved in:
| Title: | Valganciclovir Therapy Prevents Human Cytomegalovirus Reactivation in Glioblastoma Patients Undergoing Radiochemotherapy and Extends Time to Tumor Progression. |
|---|---|
| Authors: | Pantalone, Mattia Russel1,2,3 (AUTHOR) inti.peredo@regionstockholm.se, Stragliotto, Giuseppe2,4 (AUTHOR), Martin-Almazan, Nerea2,3 (AUTHOR), Peredo-Harvey, Inti1,2,4 (AUTHOR), Jimenez-Macias, Jorge L.5,6 (AUTHOR), Rahbar, Afsar2,4,6 (AUTHOR), Lawler, Sean5,6,7 (AUTHOR), Bartek, Jiri7,8,9 (AUTHOR), Söderberg-Naucler, Cecilia2,9,10 (AUTHOR) cecilia.naucler@ki.se |
| Source: | Cancers. May2026, Vol. 18 Issue 10, p1575. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers18101575 |
